Fixed typo |
Sshekhar898 (talk | contribs) Page updated with relevant improvements |
||
| Line 1: | Line 1: | ||
{{Short description| | {{Short description|Indian pharmaceutical company}} | ||
{{Use dmy dates|date= | {{Use dmy dates|date=April 2024}} | ||
{{Use Indian English|date=July 2018}} | {{Use Indian English|date=July 2018}} | ||
{{Infobox company | {{Infobox company | ||
| name = Hetero Drugs Limited | | name = Hetero Drugs Limited | ||
| logo = | | logo = Hetero_Drugs_Logo.svg | ||
| type = Private | | type = Private | ||
| industry = [[Pharmaceuticals]] | | industry = [[Pharmaceuticals]] | ||
| foundation = 1993 | | foundation = 1993 | ||
| founder = Dr | | founder = Dr. [[B. Parthasaradhi Reddy]] | ||
| location = [[Hyderabad]], [[India]] | | location = [[Hyderabad]], [[India]] | ||
| key_people = Dr Vamsi Reddy | | key_people = Dr. B. Vamsi Krishna Reddy | ||
| num_employees = Over 22,000 | | num_employees = Over 22,000 | ||
| homepage = | | homepage = {{official URL}} | ||
}} | }} | ||
'''Hetero Drugs''' is an Indian [[pharmaceutical]] company and the | '''Hetero Drugs''' is an Indian [[pharmaceutical]] company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. | ||
==Operations== | ==Operations== | ||
Hetero group employs over | Hetero group employs over 22,000 people. Hetero is a participant in the [[active pharmaceutical ingredients]] market and finished dosages.<ref name="hep-c-news1">{{cite web |url=http://hep-c-news.com/hepatitis-c-treatment-in-india-for-less-than-1000/ |title=Hepatitis C treatment in India for less than $1000 | Hep C News - Hepatitis C Treatment, Cure Rate and Cost |access-date=2016-07-11 |url-status=dead |archive-url=https://web.archive.org/web/20160916124038/http://hep-c-news.com/blog/2016/07/11/hepatitis-c-treatment-in-india-for-less-than-1000/ |archive-date=2016-09-16 }}</ref> It has marketing presence in over 140 countries. | ||
Hetero | Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharmaceuticals in the [[United States]],<ref>{{cite news |last1=Walsh |first1=James D. |title=The Empty Adderall Factory |url=https://nymag.com/intelligencer/article/adderall-shortage-adhd-medication-ascent-pharmaceuticals.html |access-date=20 February 2024 |work=Intelligencer |date=19 February 2024}}</ref> Hetero Europe in [[Europe]], Amarox Pharma Global in [[Indonesia]], and Richmond Labs in [[Argentina]]. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.<ref>{{cite web|url=http://www.heterowindpower.com/|title=Hetero Windpower|publisher=Hetero|access-date=22 June 2018}}</ref> | ||
Hetero | |||
==2009 Swine flu outbreak== | ==2009 Swine flu outbreak== | ||
In 2009, as the [[swine flu]] outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name [[Fluvir]].<ref>[http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm Swine flu: Centre taps Hetero for generic Tamiflu supply]{{webarchive |url=https://web.archive.org/web/20090430031832/http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm |date=30 April 2009 }}</ref> | In 2009, as the [[swine flu]] outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name [[Fluvir]].<ref>[http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm Swine flu: Centre taps Hetero for generic Tamiflu supply]{{webarchive |url=https://web.archive.org/web/20090430031832/http://www.thehindubusinessline.com/2009/04/29/stories/2009042952121500.htm |date=30 April 2009 }}</ref> | ||
Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,<ref>{{cite web|author=Khomba Singh | Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,<ref>{{cite web|author=Khomba Singh|url=http://economictimes.indiatimes.com/News-by-Industry/Hetero-bags-govts-anti-flu-drug-deal/articleshow/4484144.cms |title=Hetero bags mega chunk of govt's anti-flu drug deal |work=The Economic Times |date=2009-05-05 |access-date=2014-01-11}}</ref> and shipped about 80 million doses to over 60 countries.<ref>{{cite web|url=http://www.moneycontrol.com/india/news/cnbc-tv18-comments/hyderabad-pharma-cos-cashon-swine-flu-fever/411305 |title=Hyderabad pharma cos cash in on Swine-Flu fever |publisher=Moneycontrol.com |access-date=2014-01-11}}</ref> Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.<ref>{{cite web|author=Khomba Singh|url=http://economictimes.indiatimes.com/News/News-By-Industry/Healthcare-Biotech/Pharmaceuticals/Hetero-bags-deal-for-10-m-Tamiflu/articleshow/4921285.cms |title=Hetero bags deal for 10 m Tamiflu|work=The Economic Times |date=2009-08-22 |access-date=2014-01-11}}</ref> | ||
==COVID-19 experimental drugs== | ==COVID-19 experimental drugs== | ||
The company has launched the generic version of experimental [[COVID-19]] drug ''[[Remdesivir]]'' under brand name '''Covifor''' after acquiring license from [[Gilead Sciences]] and obtaining approval from [[Central Drugs Standard Control Organisation|CDSCO]], the Indian drug control authority.<ref>{{cite news |title=Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial |url=https://indianexpress.com/article/cities/hyderabad/coronavirus-drug-remdesivir-generic-version-price-6475304/ |work=The Indian Express |date=25 June 2020 | The company has launched the generic version of experimental [[COVID-19]] drug ''[[Remdesivir]]'' under brand name '''Covifor''' after acquiring license from [[Gilead Sciences]] and obtaining approval from [[Central Drugs Standard Control Organisation|CDSCO]], the Indian drug control authority.<ref>{{cite news |title=Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial |url=https://indianexpress.com/article/cities/hyderabad/coronavirus-drug-remdesivir-generic-version-price-6475304/ |work=The Indian Express |date=25 June 2020}}</ref> On 29 July 2020, the company launched its version of the anti viral drug [[Favipiravir]] under the brand name Favivir, after getting approval from [[Drugs Controller General of India]] (DCGI), used in the treatment of mild to moderate [[COVID-19]] patients.<ref>{{Cite news|last=Kumar|first=N. Ravi|date=2020-07-29|title=India's Hetero Labs wins approval to sell COVID-19 drug favipiravir|work=The Hindu|url=https://www.thehindu.com/news/national/indias-hetero-labs-wins-approval-to-sell-covid-19-drug-favipiravir/article32218999.ece|access-date=2020-09-09|issn=0971-751X}}</ref> On 27 November 2020, Hetero Labs signed an agreement with the [[Russian Direct Investment Fund|Russian Direct Investment Fund (RDIF)]] to manufacture 100 million doses of the [[Gam-COVID-Vac|Sputnik V vaccine]].<ref>{{Cite news|last=Das|first=Sohini|date=2020-11-27|title=Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India|work=Business Standard India|url=https://www.business-standard.com/article/companies/hetero-labs-to-manufacture-100-mn-doses-of-sputnik-v-vaccine-for-india-120112700495_1.html|access-date=2020-11-28}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 18:26, 30 December 2025
 | |
| Industry | Pharmaceuticals |
|---|---|
| Founded | 1993 |
| Founder(s) | Dr. B. Parthasaradhi Reddy |
| Headquarters | Hyderabad, India |
Key people | Dr. B. Vamsi Krishna Reddy |
Number of employees | Over 22,000 |
| Website | {{URL|example.com|optional display text}} |
Hetero Drugs is an Indian pharmaceutical company and the world's largest producer of anti-retroviral drugs. Hetero's business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.
Operations[edit | edit source]
Hetero group employs over 22,000 people. Hetero is a participant in the active pharmaceutical ingredients market and finished dosages.[1] It has marketing presence in over 140 countries.
Hetero Group's subsidiaries include Hetero Drugs, Hetero Labs, Hetero Research Foundation, Genx Laboratories and also foreign subsidiaries such as Camber Pharmaceuticals in the United States,[2] Hetero Europe in Europe, Amarox Pharma Global in Indonesia, and Richmond Labs in Argentina. The group is also investing in the wind power industry with a goal to reach 1000 megawatts by 2017.[3]
2009 Swine flu outbreak[edit | edit source]
In 2009, as the swine flu outbreak was spreading across the globe and various health organizations and government agencies were piling up stocks of Oseltamivir as precautionary measures, Hetero supplied generic Oseltamivir under its brand name Fluvir.[4]
Hetero delivered 10 million doses of Oseltamivir to the Indian government in 2009,[5] and shipped about 80 million doses to over 60 countries.[6] Hetero received its second order from Indian government to supply another 10 million doses of Oseltamivir later in 2009.[7]
COVID-19 experimental drugs[edit | edit source]
The company has launched the generic version of experimental COVID-19 drug Remdesivir under brand name Covifor after acquiring license from Gilead Sciences and obtaining approval from CDSCO, the Indian drug control authority.[8] On 29 July 2020, the company launched its version of the anti viral drug Favipiravir under the brand name Favivir, after getting approval from Drugs Controller General of India (DCGI), used in the treatment of mild to moderate COVID-19 patients.[9] On 27 November 2020, Hetero Labs signed an agreement with the Russian Direct Investment Fund (RDIF) to manufacture 100 million doses of the Sputnik V vaccine.[10]
References[edit | edit source]
- ↑ "Hepatitis C treatment in India for less than $1000 | Hep C News - Hepatitis C Treatment, Cure Rate and Cost". Archived from the original on 16 September 2016. Retrieved 11 July 2016.
- ↑ Walsh, James D. (19 February 2024). "The Empty Adderall Factory". Intelligencer. Retrieved 20 February 2024.
- ↑ "Hetero Windpower". Hetero. Retrieved 22 June 2018.
- ↑ Swine flu: Centre taps Hetero for generic Tamiflu supplyArchived 30 April 2009 at the Wayback Machine
- ↑ Khomba Singh (5 May 2009). "Hetero bags mega chunk of govt's anti-flu drug deal". The Economic Times. Retrieved 11 January 2014.
- ↑ "Hyderabad pharma cos cash in on Swine-Flu fever". Moneycontrol.com. Retrieved 11 January 2014.
- ↑ Khomba Singh (22 August 2009). "Hetero bags deal for 10 m Tamiflu". The Economic Times. Retrieved 11 January 2014.
- ↑ "Covid-19: Hyderabad-based Hetero Labs Ltd prices generic version of remdesivir at Rs 5,400 per vial". The Indian Express. 25 June 2020.
- ↑ Kumar, N. Ravi (29 July 2020). "India's Hetero Labs wins approval to sell COVID-19 drug favipiravir". The Hindu. ISSN 0971-751X. Retrieved 9 September 2020.
- ↑ Das, Sohini (27 November 2020). "Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for India". Business Standard India. Retrieved 28 November 2020.